Compounds > physostigmine
Page last updated: 2024-08-17

physostigmine and Encephalopathy, Toxic

physostigmine has been researched along with Encephalopathy, Toxic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Bohnenberger, K; Saadi, R1
Bonte, FJ; Carmack, PS; Devous, MD; Gunst, RF; Haley, RW; Petty, F; Schucany, WR; Spence, JS; Trivedi, MH1
Bird, SB; Rosenbaum, C1
Abou-Donia, MB; Attia, MK; Damodaran, TV1
Armstrong, S; Mumford, H; Price, M; Scott, L; Wetherell, J1

Reviews

1 review(s) available for physostigmine and Encephalopathy, Toxic

ArticleYear
Physostigmine for Antimuscarinic Toxicity.
    Journal of emergency nursing, 2020, Volume: 46, Issue:1

    Topics: Cholinesterase Inhibitors; Delirium; Emergency Nursing; Humans; Muscarinic Antagonists; Neurotoxicity Syndromes; Physostigmine

2020

Other Studies

4 other study(ies) available for physostigmine and Encephalopathy, Toxic

ArticleYear
Abnormal brain response to cholinergic challenge in chronic encephalopathy from the 1991 Gulf War.
    Psychiatry research, 2009, Mar-31, Volume: 171, Issue:3

    Topics: Adult; Brain; Cholinesterase Inhibitors; Dominance, Cerebral; Environmental Exposure; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Neurons; Neuropsychological Tests; Neurotoxicity Syndromes; Persian Gulf Syndrome; Physostigmine; Receptors, Cholinergic; Regional Blood Flow; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon; Veterans

2009
Timing and frequency of physostigmine redosing for antimuscarinic toxicity.
    Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2010, Volume: 6, Issue:4

    Topics: Adult; Akathisia, Drug-Induced; Autonomic Nervous System; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Length of Stay; Male; Middle Aged; Muscarinic Antagonists; Neurotoxicity Syndromes; Physostigmine; Retrospective Studies; Treatment Outcome; Young Adult

2010
Early differential cell death and survival mechanisms initiate and contribute to the development of OPIDN: a study of molecular, cellular, and anatomical parameters.
    Toxicology and applied pharmacology, 2011, Nov-01, Volume: 256, Issue:3

    Topics: Animals; Apoptosis; Atropine; Blotting, Northern; Brain; Cell Death; Cell Survival; Chickens; Cholinesterase Inhibitors; Female; Isoflurophate; Neurotoxicity Syndromes; Organophosphorus Compounds; Physostigmine; Spinal Cord; Time Factors

2011
Development of next generation medical countermeasures to nerve agent poisoning.
    Toxicology, 2007, Apr-20, Volume: 233, Issue:1-3

    Topics: Animals; Antidotes; Atropine; Chemical Warfare Agents; Dipeptides; Disease Models, Animal; Drug Therapy, Combination; Guinea Pigs; Ileal Diseases; Intussusception; Lethal Dose 50; Male; Neurotoxicity Syndromes; Oximes; Physostigmine; Pyridinium Compounds; Scopolamine Derivatives; Soman; Time Factors

2007